Background: High-risk human papillomavirus (HR-HPV) is the primary cause of cervical cancer, leading to over 311 000 global deaths, mainly in low- and middle-income countries. Kenyan women living with HIV (WLHIV) face a disproportionate burden of HR-HPV.Objectives: We determined the prevalence of HR-HPV infections and their association with cervical cytology findings among Kenyan WLHIV.Method: We conducted a cross-sectional study among WLHIV attending the HIV care and treatment clinic at the Kenyatta National Hospital (KNH), Kenya’s national referral hospital. Study nurses collected a cervical sample with a cytobrush for HR-HPV genotyping using Gene Xpert® assays and HPV Genotypes 14 Real-TM Quant V67-100FRT. Bivariate analysis explored the associations.Results: We enrolled 647 WLHIV (mean age of 42.8 years), with 97.2% on antiretroviral therapy (ART) and 79% with a suppressed viral load ( 50 copies/mL plasma). The prevalence of any and vaccine-preventable HR-HPV was 34.6% and 29.4%, respectively, with HPV 52 being the most common genotype (13.4%). Among WLHIV with HR-HPV infections, 21.4% had abnormal cervical cytology. Women with multiple HR-HPV infections were more likely to have abnormal cytology compared to those with single HR-HPV infections (34.9 vs 9.3%, adjusted odds ratio [aOR] = 6.2, 95% confidence interval [CI]: 2.7–14.1, P = 0.001). Women with HR-HPV infection (single or multiple) were more likely to be on the second-line ART regimen compared to those without HR-HPV infections (53.1% vs 46.7%, aOR = 2.3, 95% CI: 1.3–4.1, P = 0.005).Conclusion: Among WLHIV at KNH, abnormal cytology was common and more frequent among women with multiple HR-HPV infections.

The geographic and evolutionary origins of the SARS-CoV-2 Omicron variant (BA.1), which was first detected mid-November 2021 in Southern Africa, remain unknown. We tested 13,097 COVID-19 patients sampled between mid-2021 to early 2022 from 22 African countries for BA.1 by real-time RT-PCR. By November-December 2021, BA.1 had replaced the Delta variant in all African sub-regions following a South-North gradient, with a peak Rt of 4.1. Polymerase chain reaction and near-full genome sequencing data revealed genetically diverse Omicron ancestors already existed across Africa by August 2021. Mutations, altering viral tropism, replication and immune escape, gradually accumulated in the spike gene. Omicron ancestors were therefore present in several African countries months before Omicron dominated transmission. These data also indicate that travel bans are ineffective in the face of undetected and widespread infection.

The parasitic plant Striga hermonthica (Delile) Benth. is stimulated to germinate by biomolecules (strigolactones) produced in the roots of host and some non-host plants. Non-hosts induce Striga’s suicidal germination and are therefore used as trap crops. Among trap crops, the Slenderleaf legume in the genus Crotalaria (Crotalaria brevidens (L.) Benth.) and (Crotalaria orchroleuca (G.) Don.) has been popularized in African smallholder farms. However, the Striga germination efficiency of these locally grown Crotalaria varieties (landraces) is unknown. Also unclear is Crotolaria’s extent to inhibiting Striga growth, post germination. Extensive parasite penetration can expose the trap crop to secondary infections and possible phytotoxicity from Striga. We used in vitro germination assays to determine the Striga germination efficiency of 29 Crotalaria landraces. Furthermore, we determined Crotalaria’s ability to inhibit Striga attachment and growth using histological analysis. We found that: i) Crotalaria stimulated germination of Striga seeds at frequencies ranging between 15.5% and 54.5% compared to 74.2% stimulation by the synthetic strigolactone (GR24) used a positive control; ii) Crotalaria blocked Striga entry at multiple levels and did not allow growth beyond the pericycle, effectively blocking vascular connection with the non-host. Hence, Crotalaria is suitable as a trap crop in integrated Striga management.

Background: Diversification of global food systems through exploration of traditional varieties and wild edible plant species is a focal mitigation strategy for food security worldwide. The present study determined the phenomic diversity of locally available, affordable and climate-resilient cultivated and wild Crotalaria species for breeding purposes. Methods: Seed samples were collected from different administrative counties in Kenya spanning different climatic zones. Other seeds were provided by the Genetic Resources Research Institute of Kenya. A randomized complete block design with three replications was used for agro-morphological evaluation of the 83 accessions used in this study. Data on quantitative and qualitative traits was collected. Cluster analysis on R and R-studio was used to generate a dendrogram by the Euclidian genetic distance and dissimilarity indices while the non-metric multidimensional scaling (NMDS) method was used to determine the spatial interrelationship between the accessions. The Pearson’s correlation coefficients were used to determine the relationships between qualitative and quantitative traits while the principal component analysis was used to discriminate the accessions. Results: Three edible species (C. brevidens Benth., C. ochroleuca G.Don, C. trichotoma Bojer.) were found to be cultivated by Kenyan farmers and a significant variation (p < 0.0001) for all parameters under study was recorded. Agglomerative hierarchical clustering grouped the accessions into 8 major clusters. The NMDS ordination formed 15 and 6 groups based on counties and regions respectively. Conclusions: This study forms the basis for exploring novel breeding strategies among cultivated species, between wild and cultivated Crotalaria species as well as determining molecular markers linked to phenomic traits.

The effects of cytosine phosphoguanine oligodeoxynucleotides (CPG ODNs) on immune response have been demonstrated for different vaccines; however, such information is limited for the vector-based Coronavirus disease 2019 (COVID-19). This paper aims to demonstrate the potential effect of CPG ODNs on immunological response against the vector-based COVID-19 vaccine on Balb/c mice using a JNJ-78436735 Ad26.COV2-S recombinant as a model vaccine. A total of 18 BALB/c mice clustered into six groups were used. All groups were observed for 14- and 28-days post immunization. Qualitative determination of IgG was performed using indirect Enzyme-Linked Immunosorbent Assay (ELISA) and qPCR for cytokine profiling. A significant (p ≤ 0.001) rise in antibody response was observed for groups 3 and 4, who also showed increased expression levels of Tumor Necrosis Factor (TNF) and Interferon Gamma (IFN-γ). Immunological parameters for toxicity were normal in all treatment groups. We conclude that supplementing vector-based COVID-19 vaccines with CpG ODNs has the potential to boost the body’s immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.